Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

NIntellia Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
N

Intellia Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Oct 2, 2026Dube Michael PVP, Chief Accounting Officer1,864Common Stock$23.7KSell
Aug 21, 2026LEONARD JOHN MPresident and CEO2,785Common Stock$35.8KSell
Aug 20, 2026LEONARD JOHN MPresident and CEO19,890Common Stock$236.9KSell
Jul 22, 2026Dulac Edward J IIIEVP, Chief Financial Officer8,111Common Stock$92.3KSell
Jul 2, 2026Dulac Edward J IIIEVP, Chief Financial Officer4,677Common Stock$82.1KSell
Jul 1, 2026Dube Michael PVP, Chief Accounting Officer2,641Common Stock$44.1KSell
Jun 9, 2026Bhanji MunaDirector13,300Stock Option (right to buy)$180.1KGrant / award
Jun 9, 2026Bhanji MunaDirector9,200Common Stock$124.6KGrant / award
Jun 9, 2026Cohen Fred EDirector13,300Stock Option (right to buy)$180.1KGrant / award
Jun 9, 2026Cohen Fred EDirector9,200Common Stock$124.6KGrant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions
$12.69Close · Sep 22, 2026